Status In progress
Process STA
ID number 878

Provisional Schedule

Committee meeting: 1 04 January 2018
Expected publication 30 May 2018

Project Team

Project lead Jeremy Powell

Email enquiries

Consultees

Companies sponsors Leo Pharma
Others Department of Health
  NHS England
  NHS Tower Hamlets CCG
  NHS Trafford CCG
  Welsh Government
Patient carer groups Action Against Allergy
  Allergy UK
  British Skin Foundation
  Changing Faces
  Muslim Council of Britain
  Psoriasis Association
  Psoriasis and Psoriatic Arthritis Alliance
  Psoriasis Help Organisation
  South Asian Health Foundation
  Specialised Healthcare Alliance
Professional groups British Association of Dermatologists
  British Dermatological Nursing Group
  British Geriatrics Society
  British Society for Cutaneous Allergy
  British Society for Rheumatology
  Primary Care Dermatology Society
  Royal College of General Practitioners
  Royal College of Nursing
  Royal College of Pathologists
  Royal College of Physicians
  Royal Pharmaceutical Society
  Royal Society of Medicine
  UK Clinical Pharmacy Association

Commentators

Associated public health groups Public Health England
  Public Health Wales
Comparator companies AbbVie Limited (adalimumab)
  Accord Healthcare (methotrexate)
  Allergan (acitretin)
  Astellas (tacrolimus)
  B&S Colorama Pharmaceuticals (ciclosporin)
  Celgene (apremilast)
  Cubic Pharmaceuticals (ciclosporin)
  Dexcel-Pharma (ciclosporin, tacrolimus)
  Eli Lilly (ixekizumab)
  Genus Pharmaceuticals (acitretin)
  Hameln Pharmaceuticals (methotrexate)
  Hospira UK (infliximab, methotrexate)
  Janssen (ustekinumab)
  Medac (methotrexate)
  Merck Sharp & Dohme (infliximab)
  Mylan UK (ciclosporin, tacrolimus)
  Napp (infliximab)
  Novartis Pharmaceuticals (secukinumab, ciclosporin)
  Orion Pharma UK (methotrexate)
  Pfizer (etanercept, methotrexate)
  Sandoz (methotrexate, tacrolimus)
  Teva UK (methotrexate, tacrolimus)
  Wockhardt UK (methotrexate)
General commentators All Wales Therapeutics and Toxicology Centre
  Allied Health Professionals Federation
  Board of Community Health Councils in Wales
  British National Formulary
  Care Quality Commission
  Department of Health, Social Services and Public Safety for Northern Ireland
  Healthcare Improvement Scotland
  Medicines and Healthcare products Regulatory Agency
  National Association of Primary Care
  National Pharmacy Association
  NHS Alliance
  NHS Commercial Medicines Unit
  NHS Confederation
  Scottish Medicines Consortium
  Welsh Health Specialised Services Committee
Relevant research groups British Epidermo-Epidemiology Society
  Centre of Evidence-based Dermatology, University of Nottingham
  Cochrane Skin Group
  MRC Clinical Trials Unit
  National Institute for Health Research
  Skin Research Centre
  Skin Treatment & Research Trust

Timeline

Key events during the development of the guidance:

Date Update
10 August 2017 In progress, In progress
02 August 2017 Invitation to participate
26 July 2017 Referral
24 January 2017 Draft scope documents

For further information on how we develop guidance, please see our page about NICE technology appraisal guidance